Ethical Dilemma with Stakeholders
You're the CEO of a pharmaceutical company. Your best-selling drug ($2B annual revenue, used by 4 million patients for chronic pain) has…
As CEO, my priority is to protect the patients, the company’s long-term viability, and my own ethical integrity. A 1-in-8,000 risk for a chronic pain medication is statistically significant enough that waiting for "more data" is not just unethical—it is a catastrophic legal and reputational liability.Read the full answer
This is a high-stakes, multi-dimensional crisis requiring decisive action to balance ethical obligations, legal risks, financial stability, and stakeholder trust. Below is a detailed 48-hour action plan, structured to address all critical priorities while preparing for the board meeting and earnings call.Read the full answer